McGovern, Andrew P. http://orcid.org/0000-0002-6833-9399
,
Dennis, John M.
Shields, Beverley M.
Hattersley, Andrew T.
Pearson, Ewan R.
Jones, Angus G.
Funding for this research was provided by:
Medical Research Foundation (MR/N00633X/1)
Article History
Received: 5 December 2018
Accepted: 13 March 2019
First Online: 12 April 2019
Ethics approval and consent to participate
: Scientific approval was granted by the CPRD Independent Scientific Advisory Committee (ISAC 13_177R). No patient identifiable information was available to researchers. No specific ethical review was required from this study. All patients contributing data to the CPRD have the option to opt out of data sharing.
: Not applicable.
: E.R.P. declares personal fees from Eli Lilly and Company, Novo Nordisk, and AstraZeneca. A.P.M. declares previous research funding from Eli Lilly and Company, Pfizer, and AstraZeneca. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.